omadacycline has been researched along with Pneumonia--Viral* in 1 studies
1 other study(ies) available for omadacycline and Pneumonia--Viral
Article | Year |
---|---|
The antibiotic paradox: why companies can't afford to create life-saving drugs.
Topics: Administration, Intravenous; Administration, Oral; Anti-Bacterial Agents; Coronavirus Infections; COVID-19; Drug Approval; Drug Industry; Drug Resistance, Microbial; Humans; Pandemics; Pneumonia, Viral; Tetracyclines; Tigecycline; United States; United States Food and Drug Administration | 2020 |